Squarepoint’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $95.9M | Buy |
|
|||||
2025
Q1 | $6.18M | Sell |
|
|||||
2024
Q4 | $12M | Buy |
|
|||||
2024
Q3 | $2.82M | Sell |
|
|||||
2024
Q2 | $165M | Buy |
|
|||||
2024
Q1 | $28.9M | Sell |
|
|||||
2023
Q4 | $184M | Buy |
|
|||||
2023
Q3 | $54.6M | Sell |
|
|||||
2023
Q2 | $63.4M | Buy |
|
|||||
2023
Q1 | $1.39M | Sell |
|
|||||
2022
Q4 | $62.1M | Buy |
|
|||||
2022
Q3 | $11.5M | Sell |
|
|||||
2022
Q2 | $35.7M | Buy |
|
|||||
2022
Q1 | $19.3M | Sell |
|
|||||
2021
Q4 | $49.3M | Buy |
|
|||||
2021
Q3 | $35.3M | Buy |
|
|||||
2021
Q2 | $19.1M | Sell |
|
|||||
2021
Q1 | $42.7M | Buy |
|
|||||
2020
Q4 | $23.6M | Sell |
|
|||||
2020
Q3 | $28.5M | Sell |
|
|||||
2020
Q2 | $33.3M | Buy |
|
|||||
2020
Q1 | $9.44M | Buy |
|
|||||
2019
Q4 | $6.98M | Buy |
|
|||||
2019
Q3 | – | Sell |
|
|||||
2019
Q2 | $2.34M | Sell |
|
|||||
2019
Q1 | $32.6M | Buy |
|
|||||
2018
Q4 | $6.08M | Sell |
|
|||||
2018
Q3 | $9.6M | Buy |
|
|||||
2018
Q2 | $5.42M | Sell |
|
|||||
2018
Q1 | $8.07M | Sell |
|
|||||
2017
Q4 | $16.2M | Buy |
|
|||||
2017
Q3 | – | Sell |
|
|||||
2017
Q2 | $19.8M | Buy |
|
|||||
2017
Q1 | $4.32M | Buy |
|
|||||
2016
Q4 | – | Sell |
|
|||||
2016
Q3 | $18.2M | Buy |
|
|||||
2016
Q2 | $327K | Sell |
|
|||||
2016
Q1 | $443K | Buy |
|
|||||
2015
Q2 | – | Sell |
|
|||||
2015
Q1 | $479K | Buy |
|